Transcatheter Chordal Repair for Degenerative Mitral Regurgitation: Systematic Review and Meta-analysis
Clinical Snapshot
PICO Framework
| P — Population | Adults with primary degenerative mitral regurgitation |
| I — Intervention | Transcatheter chordal repair (off-pump, echocardiography-guided) |
| C — Comparator | No specific comparator (single-arm studies) |
| O — Outcomes | Mitral regurgitation severity, procedural success, 30-day mortality, stroke, myocardial infarction, reintervention rates |
Bottom Line
This meta-analysis of 17 studies (3,787 patients) suggests transcatheter chordal repair achieves high technical success (96.2%) with favorable early safety profile (1.2% 30-day mortality) in degenerative mitral regurgitation. However, significant concerns emerge regarding durability, with moderate mitral regurgitation increasing from 5.0% at discharge to 17.5% at 30 days. The evidence is limited by single-arm study designs, significant heterogeneity, and potential publication bias. While the procedure appears technically feasible with low periprocedural risk, the early recurrence pattern and acknowledged study limitations preclude definitive practice recommendations. Careful patient selection based on anatomical suitability appears crucial, and longer-term comparative studies are needed before widespread adoption.
Key Findings
P Value: Not reported in abstract
Effect Size: Procedural success rate 96.2%
Primary Outcome: Mitral regurgitation ≤ mild achieved in 93.9% at discharge, declining to 82.5% at 30 days
Nnt Or Sensitivity: Early recurrence rate 17.5% (moderate MR at 30 days vs 5.0% at discharge)
Confidence Interval: Not reported in abstract
Clinical Application
Requires specialized cardiac catheterization facilities with echocardiographic guidance capabilities Technology likely available in major tertiary cardiac centres; TGA approval status unclear; may be considered for high-risk surgical patients per CSANZ guidelines Adults with primary degenerative mitral regurgitation suitable for transcatheter intervention
Abstract
Transcatheter chordal repair enables off-pump, echocardiography-guided treatment of degenerative mitral regurgitation, but real-world outcomes remain variably reported. We performed a systematic review and meta-analysis of studies evaluating outcomes after transcatheter chordal repair in adults with primary degenerative mitral regurgitation. Pooled event rates were calculated using random-effects models. Seventeen studies (n = 3,787) were included. Mitral regurgitation ≤ mild was achieved in 93.9% of patients at discharge and 82.5% at 30 days, while moderate mitral regurgitation occurred in 5.0% and 17.5%, respectively. Procedural success was 96.2%, although small-study effects were suggested. Early adverse events were infrequent, with 30-day mortality of 1.2%, stroke of 0.7%, and myocardial infarction of 1.2%. Reintervention occurred in 4.5%. In conclusion, transcatheter chordal repair demonstrates high technical success and favorable early safety; however, early mitral regurgitation recurrence and heterogeneity highlight the need for anatomy-guided patient selection and cautious interpretation given single-arm study limitations.
References
- 1.Adrejiya, P., Mehta, K., Patel, D., Shah, A., Bergmark, B., & Sharkawi, M. (2026). Transcatheter chordal repair for degenerative mitral regurgitation: Systematic review and meta-analysis. The American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2026.03.032
Related Research
The American journal of cardiology
Systematic Review of Coronary Computed Tomography Angiography Guidance for Chronic Total Occlusion Percutaneous Coronary Intervention
18 July 2026
Medicine
Molecular profiling of coronary stent restenosis: A systematic review and functional analysis of implicated genes
28 June 2026
Cardiovascular research
Proteins targeting ischaemic-reperfusion injury and repair after myocardial infarction: a systematic literature review.
28 June 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service